# FID-007 Followed by Standard of Care Surgery in Head and Neck Cancer

Source: https://onco.cc/trials/nct06338657/  
OnCo record `nct06338657` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1 trial of FID-007 run by University of Southern California, terminated.

## Summary

FID-007 Followed by Standard of Care Surgery in Head and Neck Cancer is a phase 1 interventional study registered as NCT06338657 by University of Southern California, with 1 participants enrolled, started 2024-04-01. Conditions recorded: Head and Neck Squamous Cell Carcinoma. Interventions recorded: Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging, PEOX-based Polymer Encapsulated Paclitaxel FID-007 and Tumor Resection.

## Fields

- Kind: Trial
- Status: historic
- Last checked: 2026-11-03
- Tags: pipeline; ctgov-ingest
- Registry id: NCT06338657
- Phase: 1
- Setting: A Window of Opportunity Study of Taxanes in Head and Neck Cancer
- Sponsor: University of Southern California
- Enrolled: 1

## Sources

- ClinicalTrials.gov NCT06338657: https://clinicaltrials.gov/study/NCT06338657

## Connected records

- cancers: [Head and neck squamous cell carcinoma](https://onco.cc/cancers/head-and-neck/)
- drugs: [FID-007](https://onco.cc/drugs/fid-007/)
- companies: [Fulgent Genetics](https://onco.cc/companies/fulgent-genetics/)

---
JSON: https://onco.cc/api/v1/entities/nct06338657.json